STOCK TITAN
  1. Home
  2. APPDW

Applied Dna Stock Price, News & Analysis

APPDW OTC

Company Description

Applied Dna (OTC: APPDW) is a publicly traded company.

APPDW stock has declined 42.9% over the past year.

This page provides a comprehensive overview of APPDW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-42.86%
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Applied Dna (APPDW) stock. Over the past 12 months, the stock has lost 42.9%.

Latest News

View All
—

Applied DNA Announces Third Quarter Fiscal 2021

earnings
—

Applied DNA Secures Amendment to Master Services Agreement and Fourth Blanket Purchase Order from Linea™ COVID-19 Assay Kit Customer

covid-19
—

Applied DNA Granted U.S. Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authentication

—

Applied DNA Provides Business Update on COVID-19 Diagnostics and Testing

covid-19
—

U.S. FDA Lists Applied DNA’s Linea™ COVID-19 Assay Kit as 1 of Only 2 EUA-Authorized Tests Able to Detect S-Gene Mutation Found in SARS-CoV-2 U.K. Variant (B.1.1.7)

fda approval covid-19
—

Applied DNA Announces Preliminary Estimated First Fiscal Quarter 2021 Revenues in the Range of $1.3 Million to $1.6 Million

earnings

Applied Dna has 8 recent news articles. Key topics include earnings, covid-19, fda approval. View all APPDW news →

SEC Filings

View All

No SEC filings available for APPDW.

Financial Highlights

—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months